Skip to content

Retrospective/Prospective Data Collection on the LDR ROIC Interbody Fusion Device With VerteBRIDGE Plating

An Open-Label Clinical Study of the Safety and Efficacy of the ROI-C Anterior Cervical Interbody Fusion Device Using the VerteBRIDGE Plating System

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02104167
Enrollment
110
Registered
2014-04-04
Start date
2013-09-30
Completion date
2015-06-30
Last updated
2019-04-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Degenerative Disc Disease

Keywords

DDD, degenerative disc disease, cervical spine, fusion rate

Brief summary

The purpose of this combined retrospective and prospective clinical study is to examine the clinical outcomes of the ROI-C® anterior cervical interbody fusion device with VerteBRIDGE® plating to treat single level degenerative disc disease between C2 and T1 in the short term, with a focus on fusion rates.

Interventions

DEVICEROIC interbody cage with VerteBRIDGE plating

Sponsors

LDR Spine USA
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subject must have degenerative disc disease (DDD) of the cervical spine with accompanying radicular symptoms at one level between C2 and T1. * The subject can have the ROI-C device at only one level. * Autograft must have been used with the ROI-C device. * Subject should have had a minimum of 6 (six) weeks of non-operative treatment prior to surgery. * Subject must be at least 21 years of age at the time of surgery

Exclusion criteria

* No BMP was used in the interbody cage * Subject was a prisoner at the time of surgery * Subject was pregnant at the time of surgery * Subject had an active infection or sepsis at the time of surgery

Design outcomes

Primary

MeasureTime frameDescription
Percentage of Participants With Fusion12 months or more after device implantation; mean follow up 20.7 monthsRate of fusion using A/P, lateral, and flexion/extension radiographs at each time point; defined by the presence of bridging bone with less than 2° segmental motion in flexion/extension and less than 3mm of A/P translation.

Secondary

MeasureTime frameDescription
Mean Neck Disability Index (NDI), Visual Analog Scale (VAS)- Neck Pain, Visual Analog Scale (VAS)-Right and Left Arm Pain12 months (Last available visit) post surgeryNDI is a standard instrument for measuring self-rated disability due to neck pain. It is scored from 0-50, with results multiplied by 2 to arrive at a percentage. Lowest scores represent no disability, high scores represent worse disability. A VAS is a measurement instrument for pain that measures the degree across a continuum or straight line. The endpoints define extreme limits, from 0-10, with 0 representing no pain and 10 severe pain.

Countries

United States

Participant flow

Participants by arm

ArmCount
Operated Subjects With ROI-C Device
Subjects who were operated on or after Jan. 1, 2011 and who have a minimum of 12 months post-operative time prior to the final study visit.
110
Total110

Baseline characteristics

CharacteristicOperated Subjects With ROI-C Device
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
110 Participants
Age, Continuous51.9 Years
STANDARD_DEVIATION 10.2
Region of Enrollment
United States
110 participants
Sex: Female, Male
Female
64 Participants
Sex: Female, Male
Male
46 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 110
other
Total, other adverse events
42 / 110
serious
Total, serious adverse events
2 / 110

Outcome results

Primary

Percentage of Participants With Fusion

Rate of fusion using A/P, lateral, and flexion/extension radiographs at each time point; defined by the presence of bridging bone with less than 2° segmental motion in flexion/extension and less than 3mm of A/P translation.

Time frame: 12 months or more after device implantation; mean follow up 20.7 months

ArmMeasureValue (NUMBER)
Operated Subjects With ROI-C DevicePercentage of Participants With Fusion99.1 Percentage of Participants
Secondary

Mean Neck Disability Index (NDI), Visual Analog Scale (VAS)- Neck Pain, Visual Analog Scale (VAS)-Right and Left Arm Pain

NDI is a standard instrument for measuring self-rated disability due to neck pain. It is scored from 0-50, with results multiplied by 2 to arrive at a percentage. Lowest scores represent no disability, high scores represent worse disability. A VAS is a measurement instrument for pain that measures the degree across a continuum or straight line. The endpoints define extreme limits, from 0-10, with 0 representing no pain and 10 severe pain.

Time frame: 12 months (Last available visit) post surgery

Population: Operated Subjects

ArmMeasureGroupValue (MEAN)
Operated Subjects With ROI-C DeviceMean Neck Disability Index (NDI), Visual Analog Scale (VAS)- Neck Pain, Visual Analog Scale (VAS)-Right and Left Arm PainNDI19.0 Units on a Scale
Operated Subjects With ROI-C DeviceMean Neck Disability Index (NDI), Visual Analog Scale (VAS)- Neck Pain, Visual Analog Scale (VAS)-Right and Left Arm PainVAS Neck26.5 Units on a Scale
Operated Subjects With ROI-C DeviceMean Neck Disability Index (NDI), Visual Analog Scale (VAS)- Neck Pain, Visual Analog Scale (VAS)-Right and Left Arm PainVAS Left Arm15.3 Units on a Scale
Operated Subjects With ROI-C DeviceMean Neck Disability Index (NDI), Visual Analog Scale (VAS)- Neck Pain, Visual Analog Scale (VAS)-Right and Left Arm PainVAS Right Arm12.5 Units on a Scale

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026